138 related articles for article (PubMed ID: 8200295)
1. Exaggerated epinephrine response to hypoglycemia in a physically fit, well-controlled IDDM subject.
Davis SN; Goldstein RE; Cherrington AD; Price L
Diabetes Res Clin Pract; 1994 Jan; 22(2-3):139-46. PubMed ID: 8200295
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
Rattarasarn C; Dagogo-Jack S; Zachwieja JJ; Cryer PE
Diabetes; 1994 Jun; 43(6):809-18. PubMed ID: 8194668
[TBL] [Abstract][Full Text] [Related]
3. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
Dagogo-Jack S; Rattarasarn C; Cryer PE
Diabetes; 1994 Dec; 43(12):1426-34. PubMed ID: 7958494
[TBL] [Abstract][Full Text] [Related]
4. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect.
Bottini P; Boschetti E; Pampanelli S; Ciofetta M; Del Sindaco P; Scionti L; Brunetti P; Bolli GB
Diabetes; 1997 May; 46(5):814-23. PubMed ID: 9133549
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
Dagogo-Jack SE; Craft S; Cryer PE
J Clin Invest; 1993 Mar; 91(3):819-28. PubMed ID: 8450063
[TBL] [Abstract][Full Text] [Related]
6. Alanine and terbutaline in treatment of hypoglycemia in IDDM.
Wiethop BV; Cryer PE
Diabetes Care; 1993 Aug; 16(8):1131-6. PubMed ID: 8375243
[TBL] [Abstract][Full Text] [Related]
7. Attenuated glucose recovery from hypoglycemia in the elderly.
Marker JC; Cryer PE; Clutter WE
Diabetes; 1992 Jun; 41(6):671-8. PubMed ID: 1587394
[TBL] [Abstract][Full Text] [Related]
8. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
Fanelli C; Pampanelli S; Lalli C; Del Sindaco P; Ciofetta M; Lepore M; Porcellati F; Bottini P; Di Vincenzo A; Brunetti P; Bolli GB
Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
[TBL] [Abstract][Full Text] [Related]
9. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.
Towler DA; Havlin CE; Craft S; Cryer P
Diabetes; 1993 Dec; 42(12):1791-8. PubMed ID: 8243825
[TBL] [Abstract][Full Text] [Related]
11. Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia.
Pampanelli S; Fanelli C; Lalli C; Ciofetta M; Sindaco PD; Lepore M; Modarelli F; Rambotti AM; Epifano L; Di Vincenzo A; Bartocci L; Annibale B; Brunetti P; Bolli GB
Diabetologia; 1996 Jun; 39(6):677-86. PubMed ID: 8781763
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
Kinsley BT; Simonson DC
J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
[TBL] [Abstract][Full Text] [Related]
13. Catecholamines in prevention of hypoglycemia during exercise in humans.
Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
[TBL] [Abstract][Full Text] [Related]
14. Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDM.
Hirsch IB; Smith LJ; Havlin CE; Shah SD; Clutter WE; Cryer PE
Diabetes Care; 1990 Feb; 13(2):133-42. PubMed ID: 2190769
[TBL] [Abstract][Full Text] [Related]
15. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
[TBL] [Abstract][Full Text] [Related]
16. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
17. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic cholinergic antagonism does not enhance recovery from hypoglycemia in IDDM.
Hvidberg A; Cryer PE
Diabetes Care; 1995 Mar; 18(3):404-7. PubMed ID: 7555487
[TBL] [Abstract][Full Text] [Related]
19. Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children.
Amiel SA; Simonson DC; Sherwin RS; Lauritano AA; Tamborlane WV
J Pediatr; 1987 Jun; 110(6):832-7. PubMed ID: 3585599
[TBL] [Abstract][Full Text] [Related]
20. Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes.
Galassetti P; Tate D; Neill RA; Morrey S; Wasserman DH; Davis SN
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E16-24. PubMed ID: 14998785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
